Radiopharm Theranostics Ltd

RAD

Company Profile

  • Business description

    Radiopharm Theranostics Ltd is a clinical-stage radiotherapeutics company focused on the development of radiopharmaceutical products for diagnostic and therapeutic uses in areas of high unmet medical need. It develops and commercializes radiopharmaceutical platforms for therapeutic and diagnostic applications in precision oncology. The Company develops targeted and scientifically validated radiopharmaceutical technologies in pre-clinical and clinical stages. It has one reportable segment, being the research, development, and commercialization of health technologies. The Company operates in Australia and the United States, with maximum revenue from the United States.

  • Contact

    62 Lygon Street
    Suite 1, Level 3, Carlton South
    MelbourneVIC3053
    AUS

    T: +61 398245254

    https://www.radiopharmtheranostics.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    30 June 2027

    Employees

    14

Stocks News & Analysis

stocks

This former ASX tech darling is now 25% undervalued

Shares have fallen over 40% this year but revenue is still growing quickly.
stocks

Impact on ASX REIT from David Jones collapse

Store closures could hit landlords.
stocks

This cheap dividend share might be overlooked

Short term pain, long term potential.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,267.80104.401.14%
CAC 408,278.5945.300.55%
DAX 4026,347.4580.260.31%
Dow JONES (US)52,231.89157.86-0.30%
FTSE 10010,751.5931.28-0.29%
HKSE24,557.04108.090.44%
NASDAQ25,065.87187.27-0.74%
Nikkei 22560,459.581,684.082.87%
NZX 50 Index14,116.3751.04-0.36%
S&P 5007,520.9329.01-0.38%
S&P/ASX 2009,129.0099.301.10%
SSE Composite Index3,663.722.930.08%

Market Movers